AI has been the talk of the town in today’s clinical trial community, but deriving real value in eCOA requires a strategy aligned with the current clinical trial landscape and evolving regulatory expectations. This whitepaper explores Medidata’s vision and roadmap for AI adoption in eCOA, taking a pragmatic approach that focuses first on study build, where improved efficiency, consistency, and built-in compliance create a smoother, more successful path to FPI.

Download your copy to learn more.